Details about COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Study in Subjects With Small Primary Choroidal Melanoma
Trial ID or NCT#
Status
NOT RECRUITING
Purpose
The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.
Official Title
A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma
Eligibility Criteria
- - Diagnosis of choroidal melanoma
- - Have known contraindications or sensitivities to the study drug
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Mariana Nunez
(650) 497-7846
View on ClinicalTrials.gov
About this Clinical Trial
Study in Subjects With Small Primary Choroidal Melanoma
Your Message Will Go To
Mariana Nunez650-497-7846